Predicting treatment success with exenatide twice daily (EBID) at 6 mo: Are baseline postprandial glucose excursions important? Conference Paper uri icon

authors

  • Shaw, J
  • Gallwitz, B
  • Schernthaner, G
  • Han, J
  • Malloy, J

publication date

  • September 1, 2014